News › Clinical Practice, Industry News, News

InMode Introduces Morpheus8 Platform and Morpheus8 Body Fractional Technology

August 17, 2020

InMode Ltd., a global provider of medical technologies, has announced a new FDA clearance to market the Morpheus8 Body handpiece and Morpheus8 Platform.
Morpheus8 Body is the first intelligent, programmable, full-body fractional technology to deliver clinically proven RF energy up to a thermal depth of 8 mm (7-mm pin depth plus an additional 1-mm thermal profile), with its 40 gold-coated pins. As the first and only FDA-cleared technology to penetrate subdermal tissue with a thermal profile of 8 mm, the new Morpheus8 Body handpiece is designed to provide physicians with a faster, bigger solution to deliver customizable full-body fractional treatments. Based on the success of InMode’s proprietary technology, the new FDA clearance extends its line of subdermal adipose remodeling devices (SARDs).
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Massachusetts Med Spa Owner Pleads Guilty in Federal Counterfeit Injection Case
    • Merz Aesthetics’ Radiesse Receives FDA Approval for Décolleté Wrinkles
    • New Book “Get Found, Get Booked” Reveals a Smarter, Ethical Approach to Marketing for Med Spas and Wellness Practices
    • Bill Regulating Indiana Med Spas Has Passed: What You Need to Know and Why Collective Advocacy Matters
    • Growth, Capital and Control: Navigating Private Equity in Aesthetics